Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-03

Clinical Trial Update: Addition of Clonidine to Ropivacaine in Adductor Canal Block [Phase 4]

View source ↗

Summary

A Phase 4 trial update reports the addition of clonidine to ropivacaine for adductor canal block to manage postoperative pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonidine (clonidine)
  • Ropivacaine (Ropivacaine)

Snippet

Sponsor: University of Vermont | Conditions: Postoperative Pain | Phase 4 | Status: UNKNOWN